{"$schema": "https://iptc.org/std/ninjs/ninjs-schema_3.2.json", "uri": "urn:newsml:wireva.mib.news:story:2a7a2e1b-0b86-428b-b571-2e086164deac", "type": "composite", "version": "1", "versioncreated": "2026-10-16T07:56:02.096462Z", "firstcreated": "2026-10-16T06:35:41.957810Z", "pubstatus": "usable", "language": "es", "headline": "Un fármaco para frenar la lactancia reduce a la mitad el cáncer de mama en ratones predispuestos", "description_text": "Una investigación internacional con participación española observa que una dosis de cabergolina al finalizar la lactancia potencia la involución mamaria y retrasa la aparición de tumores en modelos animales. Datos retrospectivos de más de 150.000 mujeres apuntan en la misma dirección, aunque los científicos insisten en que aún no hay indicación preventiva.", "associations": {"item-0": {"$schema": "https://iptc.org/std/ninjs/ninjs-schema_3.2.json", "uri": "urn:newsml:wireva.mib.news:item:a5a991fb-7a7f-4108-bb43-404658786d61", "type": "text", "profile": "standard", "version": "1", "versioncreated": "2026-10-16T06:40:14.683313Z", "firstcreated": "2026-10-16T06:35:41.957810Z", "pubstatus": "usable", "urgency": 5, "language": "es", "headline": "Un fármaco para frenar la lactancia reduce a la mitad el cáncer de mama en ratones predispuestos", "byline": "Inés Benítez", "located": "Spain", "copyrightholder": "Haydamax OÜ", "copyrightnotice": "Wireva / Evolut", "usageterms": "Subscribers may republish this item in full, including translation and trimming, with the credit “Wireva / Evolut”. Set rel=canonical to https://evolut.top/sociedad/un-farmaco-para-frenar-la-lactancia-reduce-a-la-mitad-el-cancer-de-mama-en-ratones-predispuestos/ when publishing on the web.", "description_text": "Una investigación internacional con participación española observa que una dosis de cabergolina al finalizar la lactancia potencia la involución mamaria y retrasa la aparición de tumores en modelos animales. Datos retrospectivos de más de 150.000 mujeres apuntan en la misma dirección, aunque los científicos insisten en que aún no hay indicación preventiva.", "altids": {"mosaic": "a5a991fb-7a7f-4108-bb43-404658786d61", "story": "2a7a2e1b-0b86-428b-b571-2e086164deac", "slug": "un-farmaco-para-frenar-la-lactancia-reduce-a-la-mitad-el-cancer-de-mama-en-ratones-predispuestos"}, "subject": [{"name": "Society", "rel": "direct", "literal": "society", "code": "medtop:14000000", "scheme": "http://cv.iptc.org/newscodes/mediatopic/", "uri": "http://cv.iptc.org/newscodes/mediatopic/14000000"}], "place": [{"name": "Spain", "literal": "es", "code": "ES", "scheme": "http://cv.iptc.org/newscodes/countrycodes/"}], "person": [], "organisation": [], "genre": [{"name": "Standard story", "literal": "standard"}], "service": [{"name": "Wireva", "literal": "wireva"}], "associations": {"featuremedia": {"uri": "urn:newsml:wireva.mib.news:media:a1988cf3-d7cd-472e-a84b-9291931a2a77", "type": "picture", "version": "1", "pubstatus": "usable", "headline": "Un medicamento que frena la lactancia abre un camino inesperado para prevenir el cáncer de mama", "description_text": "Un fármaco para frenar la lactancia reduce a la mitad el cáncer de mama en ratones predispuestos", "copyrightholder": "nbg1.your-objectstorage.com", "copyrightnotice": "Wireva desk", "usageterms": "Supplied with the copy; origin to be confirmed by the desk before redistribution.", "altids": {"wireva": "a1988cf3-d7cd-472e-a84b-9291931a2a77"}, "extra": {"wireva:delivery_mode": "preview_and_link", "wireva:rights": {"licence": "Desk-supplied", "licence_url": "", "licence_raw": "Manual upload", "licence_verified_at": "2026-10-16T08:05:15.924289Z", "attribution_required": true, "attribution_text": "Wireva desk", "redistribution_allowed": false, "commercial_use_allowed": false, "modifications_allowed": false, "share_alike_required": false}, "wireva:provenance": {"creator": "", "source_name": "nbg1.your-objectstorage.com", "source_url": "https://nbg1.your-objectstorage.com/ckln/manual-news/trends-156-ES-3.jpg", "source_page_url": "https://nbg1.your-objectstorage.com/ckln/manual-news/trends-156-ES-3.jpg", "our_page_url": "https://claroscuro.fans/sociedad/un-farmaco-para-frenar-la-lactancia-reduce-a-la-mitad-el-cancer-de-mama-en-ratones-predispuestos/"}, "wireva:role": "lead"}, "renditions": {"preview": {"href": "https://nbg1.your-objectstorage.com/ckln/image-assets/56e1c9864948b4491eaa23029ce414a9f73c138d5f0c6580dbfcb309afc9bd8d.jpg", "mimetype": "image/jpeg", "width": 1400, "height": 788}, "source": {"href": "https://nbg1.your-objectstorage.com/ckln/manual-news/trends-156-ES-3.jpg", "mimetype": "image/jpeg"}}}}, "extra": {"wireva:story": {"uri": "urn:newsml:wireva.mib.news:story:2a7a2e1b-0b86-428b-b571-2e086164deac", "slug": "un-farmaco-para-frenar-la-lactancia-reduce-a-la-mitad-el-cancer-de-mama-en-ratones-predispuestos-20261016", "status": "updated", "languages": ["es"], "item_count": 3, "is_breaking": false}, "wireva:rights": {"class": "owned", "redistribution_allowed": true, "commercial_use_allowed": true, "modifications_allowed": true, "share_alike_required": false, "attribution_required": true, "attribution_text": "Wireva / Evolut", "canonical_required": true, "canonical_url": "https://evolut.top/sociedad/un-farmaco-para-frenar-la-lactancia-reduce-a-la-mitad-el-cancer-de-mama-en-ratones-predispuestos/", "linkback_required": true, "licence": "Wireva subscriber licence", "licence_url": "", "licensor": "Haydamax OÜ", "valid_until": null, "excerpt_max_chars": 0, "decided_by_rule": "own_production", "needs_review": false}, "wireva:provenance": {"production_method": "ai_assisted", "ai_stages": {"editing": true, "drafting": true, "headline": true, "image_selection": true}, "model": "", "human_reviewed": false, "reviewed_by": "", "reviewed_at": null, "editorial_control": true, "editorial_responsibility": "Haydamax OÜ (Wireva)", "factchecked": false, "verification_status": "unverified", "independent_confirmations": 0, "official_source_used": false, "used_press_release": false, "public_interest": true, "ai_disclosure_required": true, "ai_disclosure_text": "Este artículo se ha producido con ayuda de IA bajo la responsabilidad editorial de Haydamax OÜ.", "independence_check": {"status": "not_applicable", "score": 0.0, "checked_at": "2026-10-16T06:40:14.760230Z"}, "sources": []}, "wireva:publication": {"name": "Evolut", "domain": "evolut.top", "country": "ES", "url": "https://evolut.top/sociedad/un-farmaco-para-frenar-la-lactancia-reduce-a-la-mitad-el-cancer-de-mama-en-ratones-predispuestos/"}, "wireva:links": {"self": "https://wireva.mib.news/api/v1/items/a5a991fb-7a7f-4108-bb43-404658786d61", "html": "https://wireva.mib.news/item/a5a991fb-7a7f-4108-bb43-404658786d61/un-farmaco-para-frenar-la-lactancia-reduce-a-la-mitad-el-cancer-de-mama-en-ratones-predispuestos/", "story": "https://wireva.mib.news/story/un-farmaco-para-frenar-la-lactancia-reduce-a-la-mitad-el-cancer-de-mama-en-ratones-predispuestos-20261016/"}, "wireva:metrics": {"word_count": 614, "char_count": 4159, "reading_time_seconds": 297}}}, "item-1": {"$schema": "https://iptc.org/std/ninjs/ninjs-schema_3.2.json", "uri": "urn:newsml:wireva.mib.news:item:66ca6a31-9c95-4544-9fd6-95c9db119204", "type": "text", "profile": "standard", "version": "1", "versioncreated": "2026-10-16T07:05:19.053256Z", "firstcreated": "2026-10-16T07:00:41.957810Z", "pubstatus": "usable", "urgency": 5, "language": "es", "headline": "Un fármaco que frena la lactancia reduce a la mitad el cáncer de mama en ratones predispuestos", "byline": "Carmen Paredes", "located": "Spain", "copyrightholder": "Haydamax OÜ", "copyrightnotice": "Wireva / Comm Party", "usageterms": "Subscribers may republish this item in full, including translation and trimming, with the credit “Wireva / Comm Party”. Set rel=canonical to https://comm.party/sociedad/un-farmaco-que-frena-la-lactancia-reduce-a-la-mitad-el-cancer-de-mama-en-ratones-predispuestos/ when publishing on the web.", "description_text": "Una investigación internacional con participación española del Centro de Investigación del Cáncer de Salamanca halla que una dosis de cabergolina al terminar la lactancia retrasa los tumores en ratones con alteraciones en Brca1 y Trp53, y datos retrospectivos de más de 150.000 mujeres apuntan a una reducción del riesgo posparto. Los científicos advierten de que aún no hay indicación preventiva.", "altids": {"mosaic": "66ca6a31-9c95-4544-9fd6-95c9db119204", "story": "2a7a2e1b-0b86-428b-b571-2e086164deac", "slug": "un-farmaco-que-frena-la-lactancia-reduce-a-la-mitad-el-cancer-de-mama-en-ratones-predispuestos"}, "subject": [{"name": "Society", "rel": "direct", "literal": "society", "code": "medtop:14000000", "scheme": "http://cv.iptc.org/newscodes/mediatopic/", "uri": "http://cv.iptc.org/newscodes/mediatopic/14000000"}], "place": [{"name": "Spain", "literal": "es", "code": "ES", "scheme": "http://cv.iptc.org/newscodes/countrycodes/"}], "person": [], "organisation": [], "genre": [{"name": "Standard story", "literal": "standard"}], "service": [{"name": "Wireva", "literal": "wireva"}], "associations": {"featuremedia": {"uri": "urn:newsml:wireva.mib.news:media:a1988cf3-d7cd-472e-a84b-9291931a2a77", "type": "picture", "version": "1", "pubstatus": "usable", "headline": "Un medicamento que frena la lactancia abre un camino inesperado para prevenir el cáncer de mama", "description_text": "Un fármaco para frenar la lactancia reduce a la mitad el cáncer de mama en ratones predispuestos", "copyrightholder": "nbg1.your-objectstorage.com", "copyrightnotice": "Wireva desk", "usageterms": "Supplied with the copy; origin to be confirmed by the desk before redistribution.", "altids": {"wireva": "a1988cf3-d7cd-472e-a84b-9291931a2a77"}, "extra": {"wireva:delivery_mode": "preview_and_link", "wireva:rights": {"licence": "Desk-supplied", "licence_url": "", "licence_raw": "Manual upload", "licence_verified_at": "2026-10-16T08:05:15.924289Z", "attribution_required": true, "attribution_text": "Wireva desk", "redistribution_allowed": false, "commercial_use_allowed": false, "modifications_allowed": false, "share_alike_required": false}, "wireva:provenance": {"creator": "", "source_name": "nbg1.your-objectstorage.com", "source_url": "https://nbg1.your-objectstorage.com/ckln/manual-news/trends-156-ES-3.jpg", "source_page_url": "https://nbg1.your-objectstorage.com/ckln/manual-news/trends-156-ES-3.jpg", "our_page_url": "https://claroscuro.fans/sociedad/un-farmaco-para-frenar-la-lactancia-reduce-a-la-mitad-el-cancer-de-mama-en-ratones-predispuestos/"}, "wireva:role": "lead"}, "renditions": {"preview": {"href": "https://nbg1.your-objectstorage.com/ckln/image-assets/56e1c9864948b4491eaa23029ce414a9f73c138d5f0c6580dbfcb309afc9bd8d.jpg", "mimetype": "image/jpeg", "width": 1400, "height": 788}, "source": {"href": "https://nbg1.your-objectstorage.com/ckln/manual-news/trends-156-ES-3.jpg", "mimetype": "image/jpeg"}}}}, "extra": {"wireva:story": {"uri": "urn:newsml:wireva.mib.news:story:2a7a2e1b-0b86-428b-b571-2e086164deac", "slug": "un-farmaco-para-frenar-la-lactancia-reduce-a-la-mitad-el-cancer-de-mama-en-ratones-predispuestos-20261016", "status": "updated", "languages": ["es"], "item_count": 3, "is_breaking": false}, "wireva:rights": {"class": "owned", "redistribution_allowed": true, "commercial_use_allowed": true, "modifications_allowed": true, "share_alike_required": false, "attribution_required": true, "attribution_text": "Wireva / Comm Party", "canonical_required": true, "canonical_url": "https://comm.party/sociedad/un-farmaco-que-frena-la-lactancia-reduce-a-la-mitad-el-cancer-de-mama-en-ratones-predispuestos/", "linkback_required": true, "licence": "Wireva subscriber licence", "licence_url": "", "licensor": "Haydamax OÜ", "valid_until": null, "excerpt_max_chars": 0, "decided_by_rule": "own_production", "needs_review": false}, "wireva:provenance": {"production_method": "ai_assisted", "ai_stages": {"editing": true, "drafting": true, "headline": true, "image_selection": true}, "model": "", "human_reviewed": false, "reviewed_by": "", "reviewed_at": null, "editorial_control": true, "editorial_responsibility": "Haydamax OÜ (Wireva)", "factchecked": false, "verification_status": "unverified", "independent_confirmations": 0, "official_source_used": false, "used_press_release": false, "public_interest": true, "ai_disclosure_required": true, "ai_disclosure_text": "Este artículo se ha producido con ayuda de IA bajo la responsabilidad editorial de Haydamax OÜ.", "independence_check": {"status": "not_applicable", "score": 0.0, "checked_at": "2026-10-16T07:05:19.062760Z"}, "sources": []}, "wireva:publication": {"name": "Comm Party", "domain": "comm.party", "country": "ES", "url": "https://comm.party/sociedad/un-farmaco-que-frena-la-lactancia-reduce-a-la-mitad-el-cancer-de-mama-en-ratones-predispuestos/"}, "wireva:links": {"self": "https://wireva.mib.news/api/v1/items/66ca6a31-9c95-4544-9fd6-95c9db119204", "html": "https://wireva.mib.news/item/66ca6a31-9c95-4544-9fd6-95c9db119204/un-farmaco-que-frena-la-lactancia-reduce-a-la-mitad-el-cancer-de-mama-en-ratones-predispuestos/", "story": "https://wireva.mib.news/story/un-farmaco-para-frenar-la-lactancia-reduce-a-la-mitad-el-cancer-de-mama-en-ratones-predispuestos-20261016/"}, "wireva:metrics": {"word_count": 641, "char_count": 4307, "reading_time_seconds": 308}}}, "item-2": {"$schema": "https://iptc.org/std/ninjs/ninjs-schema_3.2.json", "uri": "urn:newsml:wireva.mib.news:item:e96ddc52-8cef-469f-8cbd-823d9fa74325", "type": "text", "profile": "standard", "version": "1", "versioncreated": "2026-10-16T08:05:15.909733Z", "firstcreated": "2026-10-16T07:56:02.096462Z", "pubstatus": "usable", "urgency": 5, "language": "es", "headline": "Un fármaco para frenar la lactancia reduce a la mitad el cáncer de mama en ratones predispuestos", "byline": "Alba Aguilar", "located": "Spain", "copyrightholder": "Haydamax OÜ", "copyrightnotice": "Wireva / Claroscuro", "usageterms": "Subscribers may republish this item in full, including translation and trimming, with the credit “Wireva / Claroscuro”. Set rel=canonical to https://claroscuro.fans/sociedad/un-farmaco-para-frenar-la-lactancia-reduce-a-la-mitad-el-cancer-de-mama-en-ratones-predispuestos/ when publishing on the web.", "description_text": "Un estudio internacional con participación española observa que la cabergolina, usada para suprimir la lactancia, potencia la involución mamaria y retrasa los tumores en modelos animales. Datos retrospectivos de más de 150.000 mujeres apuntan a una reducción del riesgo posparto, pero los científicos insisten en que aún no hay indicación preventiva.", "altids": {"mosaic": "e96ddc52-8cef-469f-8cbd-823d9fa74325", "story": "2a7a2e1b-0b86-428b-b571-2e086164deac", "slug": "un-farmaco-para-frenar-la-lactancia-reduce-a-la-mitad-el-cancer-de-mama-en-ratones-predispuestos"}, "subject": [{"name": "Society", "rel": "direct", "literal": "society", "code": "medtop:14000000", "scheme": "http://cv.iptc.org/newscodes/mediatopic/", "uri": "http://cv.iptc.org/newscodes/mediatopic/14000000"}], "place": [{"name": "Spain", "literal": "es", "code": "ES", "scheme": "http://cv.iptc.org/newscodes/countrycodes/"}], "person": [], "organisation": [], "genre": [{"name": "Standard story", "literal": "standard"}], "service": [{"name": "Wireva", "literal": "wireva"}], "associations": {"featuremedia": {"uri": "urn:newsml:wireva.mib.news:media:a1988cf3-d7cd-472e-a84b-9291931a2a77", "type": "picture", "version": "1", "pubstatus": "usable", "headline": "Un medicamento que frena la lactancia abre un camino inesperado para prevenir el cáncer de mama", "description_text": "Un fármaco para frenar la lactancia reduce a la mitad el cáncer de mama en ratones predispuestos", "copyrightholder": "nbg1.your-objectstorage.com", "copyrightnotice": "Wireva desk", "usageterms": "Supplied with the copy; origin to be confirmed by the desk before redistribution.", "altids": {"wireva": "a1988cf3-d7cd-472e-a84b-9291931a2a77"}, "extra": {"wireva:delivery_mode": "preview_and_link", "wireva:rights": {"licence": "Desk-supplied", "licence_url": "", "licence_raw": "Manual upload", "licence_verified_at": "2026-10-16T08:05:15.924289Z", "attribution_required": true, "attribution_text": "Wireva desk", "redistribution_allowed": false, "commercial_use_allowed": false, "modifications_allowed": false, "share_alike_required": false}, "wireva:provenance": {"creator": "", "source_name": "nbg1.your-objectstorage.com", "source_url": "https://nbg1.your-objectstorage.com/ckln/manual-news/trends-156-ES-3.jpg", "source_page_url": "https://nbg1.your-objectstorage.com/ckln/manual-news/trends-156-ES-3.jpg", "our_page_url": "https://claroscuro.fans/sociedad/un-farmaco-para-frenar-la-lactancia-reduce-a-la-mitad-el-cancer-de-mama-en-ratones-predispuestos/"}, "wireva:role": "lead"}, "renditions": {"preview": {"href": "https://nbg1.your-objectstorage.com/ckln/image-assets/56e1c9864948b4491eaa23029ce414a9f73c138d5f0c6580dbfcb309afc9bd8d.jpg", "mimetype": "image/jpeg", "width": 1400, "height": 788}, "source": {"href": "https://nbg1.your-objectstorage.com/ckln/manual-news/trends-156-ES-3.jpg", "mimetype": "image/jpeg"}}}}, "extra": {"wireva:story": {"uri": "urn:newsml:wireva.mib.news:story:2a7a2e1b-0b86-428b-b571-2e086164deac", "slug": "un-farmaco-para-frenar-la-lactancia-reduce-a-la-mitad-el-cancer-de-mama-en-ratones-predispuestos-20261016", "status": "updated", "languages": ["es"], "item_count": 3, "is_breaking": false}, "wireva:rights": {"class": "owned", "redistribution_allowed": true, "commercial_use_allowed": true, "modifications_allowed": true, "share_alike_required": false, "attribution_required": true, "attribution_text": "Wireva / Claroscuro", "canonical_required": true, "canonical_url": "https://claroscuro.fans/sociedad/un-farmaco-para-frenar-la-lactancia-reduce-a-la-mitad-el-cancer-de-mama-en-ratones-predispuestos/", "linkback_required": true, "licence": "Wireva subscriber licence", "licence_url": "", "licensor": "Haydamax OÜ", "valid_until": null, "excerpt_max_chars": 0, "decided_by_rule": "own_production", "needs_review": false}, "wireva:provenance": {"production_method": "ai_assisted", "ai_stages": {"editing": true, "drafting": true, "headline": true, "image_selection": true}, "model": "", "human_reviewed": false, "reviewed_by": "", "reviewed_at": null, "editorial_control": true, "editorial_responsibility": "Haydamax OÜ (Wireva)", "factchecked": false, "verification_status": "unverified", "independent_confirmations": 0, "official_source_used": false, "used_press_release": false, "public_interest": true, "ai_disclosure_required": true, "ai_disclosure_text": "Este artículo se ha producido con ayuda de IA bajo la responsabilidad editorial de Haydamax OÜ.", "independence_check": {"status": "not_applicable", "score": 0.0, "checked_at": "2026-10-16T08:05:15.919935Z"}, "sources": []}, "wireva:publication": {"name": "Claroscuro", "domain": "claroscuro.fans", "country": "ES", "url": "https://claroscuro.fans/sociedad/un-farmaco-para-frenar-la-lactancia-reduce-a-la-mitad-el-cancer-de-mama-en-ratones-predispuestos/"}, "wireva:links": {"self": "https://wireva.mib.news/api/v1/items/e96ddc52-8cef-469f-8cbd-823d9fa74325", "html": "https://wireva.mib.news/item/e96ddc52-8cef-469f-8cbd-823d9fa74325/un-farmaco-para-frenar-la-lactancia-reduce-a-la-mitad-el-cancer-de-mama-en-ratones-predispuestos/", "story": "https://wireva.mib.news/story/un-farmaco-para-frenar-la-lactancia-reduce-a-la-mitad-el-cancer-de-mama-en-ratones-predispuestos-20261016/"}, "wireva:metrics": {"word_count": 593, "char_count": 4019, "reading_time_seconds": 287}}}}, "extra": {"wireva:languages": ["es"], "wireva:status": "updated", "wireva:item_count": 3}}